Endpoints News

China’s drugmakers to take the stage at #ASCO26

It’s no secret that Akeso’s presentation will be one of the most closely watched readouts from the American Society of Clinical Oncology annual meeting this year.

This report was first published by Endpoints News. To see the original version, click here

It’s no secret that Akeso’s presentation will be one of the most closely watched readouts from the American Society of Clinical Oncology annual meeting this year.

Slated for May 31, HARMONi-6 marks the first plenary presentation of a study conducted in China following 2021’s readout from Junshi Biosciences and Coherus. In a way, the two readouts symbolize the growth of China’s biotech industry.

您已阅读18%(486字),剩余82%(2211字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×